These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33992954)

  • 21. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
    Chang Y; Fang WB; Lin SN; Moody DE
    Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):55-62. PubMed ID: 20825389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices.
    Martin H; Sarsat JP; de Waziers I; Housset C; Balladur P; Beaune P; Albaladejo V; Lerche-Langrand C
    Pharm Res; 2003 Apr; 20(4):557-68. PubMed ID: 12739762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cyclophosphamide and CYP2B6].
    Torimoto Y; Kohgo Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1090-3. PubMed ID: 18633247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.
    Ekhart C; Doodeman VD; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
    Pharmacogenet Genomics; 2008 Jun; 18(6):515-23. PubMed ID: 18496131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
    Jacobson PA; Green K; Birnbaum A; Remmel RP
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):461-7. PubMed ID: 12107550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substantial Impairment of Voriconazole Clearance by High-Dose Meropenem in a Patient With Renal Failure.
    Mahmoudi M; Brenner T; Hatiboglu G; Burhenne J; Weiss J; Weigand MA; Haefeli WE
    Clin Infect Dis; 2017 Sep; 65(6):1033-1036. PubMed ID: 28505263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism.
    Schulz J; Kluwe F; Mikus G; Michelet R; Kloft C
    Drug Metab Rev; 2019 Aug; 51(3):247-265. PubMed ID: 31215810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomes.
    Helsby NA; Yong M; van Kan M; de Zoysa JR; Burns KE
    Br J Clin Pharmacol; 2019 Sep; 85(9):1925-1934. PubMed ID: 31218720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation.
    Helsby NA; Hui CY; Goldthorpe MA; Coller JK; Soh MC; Gow PJ; De Zoysa JZ; Tingle MD
    Br J Clin Pharmacol; 2010 Dec; 70(6):844-53. PubMed ID: 21175440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the anticancer drugs cyclophosphamide and ifosfamide by cytochrome P450 BM3 mutants.
    Vredenburg G; den Braver-Sewradj S; van Vugt-Lussenburg BM; Vermeulen NP; Commandeur JN; Vos JC
    Toxicol Lett; 2015 Jan; 232(1):182-92. PubMed ID: 25448283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of (-)-cis- and (-)-trans-rose oxide by cytochrome P450 enzymes in human liver microsomes.
    Nakahashi H; Yamamura Y; Usami A; Rangsunvigit P; Malakul P; Miyazawa M
    Biopharm Drug Dispos; 2015 Dec; 36(9):565-74. PubMed ID: 26126958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin.
    Svensson US; Ashton M
    Br J Clin Pharmacol; 1999 Oct; 48(4):528-35. PubMed ID: 10583023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics.
    Hohmann N; Kreuter R; Blank A; Weiss J; Burhenne J; Haefeli WE; Mikus G
    Br J Clin Pharmacol; 2017 Sep; 83(9):1954-1965. PubMed ID: 28370390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Hesse LM; Venkatakrishnan K; Court MH; von Moltke LL; Duan SX; Shader RI; Greenblatt DJ
    Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivo.
    Raccor BS; Claessens AJ; Dinh JC; Park JR; Hawkins DS; Thomas SS; Makar KW; McCune JS; Totah RA
    Drug Metab Dispos; 2012 Jan; 40(1):54-63. PubMed ID: 21976622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged-Release Tacrolimus Is Less Susceptible to Interaction With the Strong CYP3A Inhibitor Voriconazole in Healthy Volunteers.
    Huppertz A; Ott C; Bruckner T; Foerster KI; Burhenne J; Weiss J; Zorn M; Haefeli WE; Czock D
    Clin Pharmacol Ther; 2019 Dec; 106(6):1290-1298. PubMed ID: 31152598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
    Gerber JG; Rhodes RJ; Gal J
    Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism.
    de Jonge ME; Huitema AD; Holtkamp MJ; van Dam SM; Beijnen JH; Rodenhuis S
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):370-8. PubMed ID: 15838656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative in vitro phenotyping and prediction of drug interaction potential of CYP2B6 substrates as victims.
    Palacharla RC; Nirogi R; Uthukam V; Manoharan A; Ponnamaneni RK; Kalaikadhiban I
    Xenobiotica; 2018 Jul; 48(7):663-675. PubMed ID: 28737446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes.
    Xing J; Kirby BJ; Whittington D; Wan Y; Goodlett DR
    Drug Metab Dispos; 2012 Sep; 40(9):1757-64. PubMed ID: 22679214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.